Cargando…

The clinical potential of blood-proteomics in multiple sclerosis

BACKGROUND: The aetiology of multiple sclerosis (MS) remains unknown. This hampers molecular diagnosis and the discovery of bio-molecular markers. Consequently, MS diagnostic procedures are complex and criteria for assessing therapeutic efficacy are controversial, suggesting that a pathophysiologica...

Descripción completa

Detalles Bibliográficos
Autores principales:	De Masi, Roberto, Pasca, Sergio, Scarpello, Rocco, Idolo, Adele, De Donno, Antonella
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3674984/ https://www.ncbi.nlm.nih.gov/pubmed/23692923 http://dx.doi.org/10.1186/1471-2377-13-45

Ejemplares similares

Dramatic recovery of steroid-refractory relapsed multiple sclerosis following Fingolimod discontinuation using selective immune adsorption
por: De Masi, Roberto, et al.
Publicado: (2015)

Progressive familial intrahepatic cholestasis type‐3 and multiple sclerosis: lessons from comorbidity
por: De Masi, Roberto, et al.
Publicado: (2019)

The Age-Related Efficacy of Dimethyl Fumarate and Natalizumab in the Real-World Management of Multiple Sclerosis
por: De Masi, Roberto, et al.
Publicado: (2021)

Emergence of unusual human rotavirus strains in Salento, Italy, during 2006–2007
por: De Donno, Antonella, et al.
Publicado: (2009)

The Water Safety Plan Approach: Application to Small Drinking-Water Systems—Case Studies in Salento (South Italy)
por: Serio, Francesca, et al.
Publicado: (2021)

Multi-Criterial Model for Weighting Biological Risk Factors in Multiple Sclerosis: Clinical and Health Insurance Implications
por: De Masi, Roberto, et al.
Publicado: (2023)

Early-Life Exposure to Environmental Air Pollution and Autism Spectrum Disorder: A Review of Available Evidence
por: Imbriani, Giovanni, et al.
Publicado: (2021)

Micronucleus Frequency in Exfoliated Buccal Cells of Children Living in an Industrialized Area of Apulia (Italy)
por: Panico, Alessandra, et al.
Publicado: (2020)

Heavy Environmental Pressure in Campania and Other Italian Regions: A Short Review of Available Evidence
por: Mazza, Alfredo, et al.
Publicado: (2018)

Proteomic Profiling in Multiple Sclerosis Clinical Courses Reveals Potential Biomarkers of Neurodegeneration
por: Liguori, Maria, et al.
Publicado: (2014)

Micronuclei in Exfoliated Buccal Cells of Children Living in a Cluster Area of Salento (Southern Italy) with a High Incidence of Lung Cancer: The IMP.AIR Study
por: Idolo, Adele, et al.
Publicado: (2018)

Impact of Stinging Jellyfish Proliferations along South Italian Coasts: Human Health Hazards, Treatment and Social Costs
por: De Donno, Antonella, et al.
Publicado: (2014)

GANAB as a Novel Biomarker in Multiple Sclerosis: Correlation with Neuroinflammation and IFI35
por: De Masi, Roberto, et al.
Publicado: (2021)

GANAB and N-Glycans Substrates Are Relevant in Human Physiology, Polycystic Pathology and Multiple Sclerosis: A Review
por: De Masi, Roberto, et al.
Publicado: (2022)

Plasma proteome in multiple sclerosis disease progression
por: Malekzadeh, Arjan, et al.
Publicado: (2019)

Proteomics in Multiple Sclerosis: The Perspective of the Clinician
por: Sandi, Dániel, et al.
Publicado: (2022)

The Urine Proteome Profile Is Different in Neuromyelitis Optica Compared to Multiple Sclerosis: A Clinical Proteome Study
por: Nielsen, Helle H., et al.
Publicado: (2015)

CSF Proteomics Identifies Specific and Shared Pathways for Multiple Sclerosis Clinical Subtypes
por: Avsar, Timucin, et al.
Publicado: (2015)

IFP35 Is a Relevant Factor in Innate Immunity, Multiple Sclerosis, and Other Chronic Inflammatory Diseases: A Review
por: De Masi, Roberto, et al.
Publicado: (2021)

Increased level of fibrinogen chains in the proteome of blood platelets in secondary progressive multiple sclerosis patients
por: Bijak, Michal, et al.
Publicado: (2019)

Skin safety and health prevention: an overview of chemicals in cosmetic products
por: PANICO, A., et al.
Publicado: (2019)

Nutrition Facts in Multiple Sclerosis
por: Riccio, Paolo, et al.
Publicado: (2015)

The NACT Training Package
por: Scarpello, John H. B.
Publicado: (1991)

Multiple Sclerosis Biomarker Discoveries by Proteomics and Metabolomics Approaches
por: Jafari, Ameneh, et al.
Publicado: (2021)

Health Risk Associated with Exposure to PM(10) and Benzene in Three Italian Towns
por: De Donno, Antonella, et al.
Publicado: (2018)

Water Quality Assessment: A Quali-Quantitative Method for Evaluation of Environmental Pressures Potentially Impacting on Groundwater, Developed under the M.I.N.O.Re. Project
por: De Filippis, Giovanni, et al.
Publicado: (2020)

Proteomic analysis of cerebrospinal fluid for relapsing-remitting multiple sclerosis and clinically isolated syndrome
por: PAVELEK, ZBYŠEK, et al.
Publicado: (2016)

Digital Innovation in Multiple Sclerosis Management
por: Ziemssen, Tjalf, et al.
Publicado: (2021)

Tests on peripheral blood cells in multiple sclerosis.
por: McCrea, S., et al.
Publicado: (1979)

Quantitative proteomic analysis of the cerebrospinal fluid of patients with multiple sclerosis
por: Liu, Shilian, et al.
Publicado: (2009)

Development of robust targeted proteomics assays for cerebrospinal fluid biomarkers in multiple sclerosis
por: Guldbrandsen, Astrid, et al.
Publicado: (2020)

Integrative biochemical, proteomics and metabolomics cerebrospinal fluid biomarkers predict clinical conversion to multiple sclerosis
por: Probert, Fay, et al.
Publicado: (2021)

Involvement of Oxidative Stress in Occurrence of Relapses in Multiple Sclerosis: The Spectrum of Oxidatively Modified Serum Proteins Detected by Proteomics and Redox Proteomics Analysis
por: Fiorini, Ada, et al.
Publicado: (2013)

Digital Twins for Multiple Sclerosis
por: Voigt, Isabel, et al.
Publicado: (2021)

The Refinement of Genetic Predictors of Multiple Sclerosis
por: Disanto, Giulio, et al.
Publicado: (2014)

Dupilumab in patients with moderate to severe atopic dermatitis and multiple sclerosis
por: Esposito, Maria, et al.
Publicado: (2022)

Potentially Common Therapeutic Targets for Multiple Sclerosis and Ischemic Stroke
por: Paternò, Roberto, et al.
Publicado: (2018)

Clinical trials in multiple sclerosis: potential future trial designs
por: Manouchehri, Navid, et al.
Publicado: (2019)

Proteomics Comparison of Cerebrospinal Fluid of Relapsing Remitting and Primary Progressive Multiple Sclerosis
por: Stoop, Marcel P., et al.
Publicado: (2010)

Brain proteome‐wide association study linking‐genes in multiple sclerosis pathogenesis
por: Jia, Tingting, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_1fml0enah5fmjkve5kadi4ta9a